Clinical Trial Detail

NCT ID NCT04259450
Title Study to Assess AFM24 in Advanced Solid Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Affimed GmbH
Indications

ovarian cancer

lung cancer

breast cancer

transitional cell carcinoma

esophageal cancer

stomach cancer

colorectal cancer

kidney cancer

cervical cancer

glioblastoma multiforme

head and neck cancer

Advanced Solid Tumor

pancreatic cancer

Therapies

AFM24

Age Groups: adult senior

No variant requirements are available.